These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 10873423)

  • 21. Expression of intracellular interferon constitutively activates ISGF3 and confers resistance to EMC viral infection.
    Rutherford MN; Kumar A; Coulombe B; Skup D; Carver DH; Williams BR
    J Interferon Cytokine Res; 1996 Jul; 16(7):507-10. PubMed ID: 8836915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of 2'-5'-oligoadenylate synthetase in gamma-interferon-mediated growth inhibition of A431 cells.
    Kumar R; Mendelsohn J
    Cancer Res; 1989 Sep; 49(18):5180-4. PubMed ID: 2504485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of 2,5-oligoadenylate synthetase and protein kinase activities in clinical studies of larifan and recombinant interferon alpha in volunteers].
    Sokolova TM; Nosik NN; Lopatina OA; Krylov VF
    Antibiot Khimioter; 1991 Jul; 36(7):42-5. PubMed ID: 1953190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of antiviral action of interferon.
    Baglioni C; Nilsen TW
    Interferon; 1983; 5():23-42. PubMed ID: 6202642
    [No Abstract]   [Full Text] [Related]  

  • 25. A bioassay for serum interferon based on induction of 2'5'-oligoadenylate synthetase activity.
    Uno K; Sato T; Takada Y; Fujioka K; Suginoshita Y; Kakimi K; Moriyasu F; Kishida T
    J Interferon Cytokine Res; 1998 Dec; 18(12):1011-8. PubMed ID: 9877443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antiviral and antiproliferative activity of human fibroblast interferon fractions].
    Balandin IG; Kristin TI; Itkes AV; Solov'eva MF; Kalmakhelidze KA
    Mol Gen Mikrobiol Virusol; 1986 Dec; (12):44-8. PubMed ID: 3807930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon induction, 2'-5' oligo A synthetase and lymphocyte subpopulations in out-patients with multiple sclerosis in a longitudinal study.
    Haahr S; Møller-Larsen A; Justesen J; Pedersen E
    Acta Neurol Scand; 1986 Apr; 73(4):345-51. PubMed ID: 2425539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alternative splicing coupled with transcript degradation modulates OAS1g antiviral activity.
    Frankiw L; Mann M; Li G; Joglekar A; Baltimore D
    RNA; 2020 Feb; 26(2):126-136. PubMed ID: 31740586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The activity of 2',5'-oligoadenylate-synthetase in rat spleen lymphocytes in the chronic ethanol intoxication and administration of zinc acetate].
    Chaĭka VO; Kompanets' IV; Hadiliia OP; Kharchenko OI; Ostapchenko LI
    Ukr Biokhim Zh (1999); 2010; 82(4):100-4. PubMed ID: 21516723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Whole-genome expression analyses of type 2 diabetes in human skin reveal altered immune function and burden of infection.
    Wu C; Chen X; Shu J; Lee CT
    Oncotarget; 2017 May; 8(21):34601-34609. PubMed ID: 28427244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RNase L contributes to experimentally induced type 1 diabetes onset in mice.
    Zeng C; Yi X; Zipris D; Liu H; Zhang L; Zheng Q; Malathi K; Jin G; Zhou A
    J Endocrinol; 2014 Dec; 223(3):277-87. PubMed ID: 25287058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2'-5' oligoadenylate synthetase 1 polymorphism is associated with prostate cancer.
    Mandal S; Abebe F; Chaudhary J
    Cancer; 2011 Dec; 117(24):5509-18. PubMed ID: 21638280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single nucleotide polymorphism at exon 7 splice acceptor site of OAS1 gene determines response of hepatitis C virus patients to interferon therapy.
    El Awady MK; Anany MA; Esmat G; Zayed N; Tabll AA; Helmy A; El Zayady AR; Abdalla MS; Sharada HM; El Raziky M; El Akel W; Abdalla S; Bader El Din NG
    J Gastroenterol Hepatol; 2011 May; 26(5):843-50. PubMed ID: 21182542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transformation of SV40-immortalized human uroepithelial cells by 3-methylcholanthrene increases IFN- and Large T Antigen-induced transcripts.
    Crosby LM; Moore TM; George M; Yoon LW; Easton MJ; Ni H; Morgan KT; DeAngelo AB
    Cancer Cell Int; 2010 Feb; 10():4. PubMed ID: 20178601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Murine pancreatic beta TC3 cells show greater 2', 5'-oligoadenylate synthetase (2'5'AS) antiviral enzyme activity and apoptosis following IFN-alpha or poly(I:C) treatment than pancreatic alpha TC3 cells.
    Li M; Zheng DJ; Field LL; Bonnevie-Nielsen V
    Exp Diabetes Res; 2009; 2009():631026. PubMed ID: 19888425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Could 2'5'-oligoadenylate synthetase isoforms be biomarkers to differentiate between disease flare and infection in lupus patients? A pilot study.
    Ye S; Guo Q; Tang JP; Yang CD; Shen N; Chen SL
    Clin Rheumatol; 2007 Feb; 26(2):186-90. PubMed ID: 16565890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Type 1 diabetes and the OAS gene cluster: association with splicing polymorphism or haplotype?
    Tessier MC; Qu HQ; Fréchette R; Bacot F; Grabs R; Taback SP; Lawson ML; Kirsch SE; Hudson TJ; Polychronakos C
    J Med Genet; 2006 Feb; 43(2):129-32. PubMed ID: 16014697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variation in antiviral 2',5'-oligoadenylate synthetase (2'5'AS) enzyme activity is controlled by a single-nucleotide polymorphism at a splice-acceptor site in the OAS1 gene.
    Bonnevie-Nielsen V; Field LL; Lu S; Zheng DJ; Li M; Martensen PM; Nielsen TB; Beck-Nielsen H; Lau YL; Pociot F
    Am J Hum Genet; 2005 Apr; 76(4):623-33. PubMed ID: 15732009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence from twins for acquired cellular immune hyperactivity in type 1 diabetes.
    Petrovsky N; Kyvik KO; Bonnevie-Nielsen V; Beck-Nielsen H; Green A; Harrison LC
    Immunology; 2002 Aug; 106(4):584-9. PubMed ID: 12153522
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.